title: Changes in vascular basement membrane in the endometrium of Norplant users.
abstract: Progestogen-only contraception is almost invariably associated with changes in menstrual bleeding patterns. Changes in the endometrial vasculature, and in particular an increase in vascular fragility, may contribute to this bleeding. In this study, endometrial vascular density and endothelial cell basement membrane components were examined using immunohistochemistry before and after insertion of Norplant. Endometrial vascular density was increased from a mean (+/- SEM) of 189.6 +/- 7.0 vessels/mm2 during the control cycle to 253.9 +/- 80.7 vessels/mm2 at 2-13 weeks of Norplant exposure, and to 212.7 +/- 12.9 vessels/mm2 at 14-42 weeks. During the control cycle, a mean of 161.4 +/- 4.5 vessels/mm2 stained for collagen IV (85% of all vessels), while at 2-13 weeks, 144.5 +/- 13.0 vessels/mm2 stained for collagen IV (57% of all vessels) (t ratio = 2.08, P = 0.0057). By 14-42 weeks, 71% of vessels (151.0 +/- 9.8) vessels/mm2 were surrounded by collagen IV. This was not significantly different from control values (t ratio = 2.03). Endometrial vascular laminin was also reduced following Norplant insertion, from a mean of 176.0 +/- 4.2 vessels/mm2 in the control cycle (93% of vessels), to 156.3 +/- 6.7 vessels/mm2 at 2-13 weeks of exposure (57% of vessels) (t ratio = 2.08, P = 0.01). By 14-42 weeks of exposure to Norplant, 162.5 +/- 9 vessels/mm2 (76%) stained for laminin. This was not significantly different from control values (t ratio = 2.04). Endometrial vascular heparan sulphate proteoglycan (HSPG) was reduced from 58.6 +/- 3.0 vessels/mm2 during the control cycle (31% of vessels) to 43.6 +/- 5.6 vessels/mm2 (only 17% of vessels) at 2-13 weeks (t ratio = 2.08, P = 0.025). At 14-42 weeks, only 19% of vessels stained for HSPG (41.3 +/- 5.8 vessels/mm2; t ratio = 2.04, P = 0.009).
authors.affiliation: Department of Obstetrics and Gynaecology, Imperial College School of Medicine at St. Mary's, London.
authors.forename: M
authors.initials: M
authors.lastname: Hickey
authors.forename: M
authors.initials: M
authors.lastname: Simbar
authors.forename: R
authors.initials: R
authors.lastname: Markham
authors.forename: L
authors.initials: L
authors.lastname: Young
authors.forename: F
authors.initials: F
authors.lastname: Manconi
authors.forename: P
authors.initials: P
authors.lastname: Russell
authors.forename: I S
authors.initials: IS
authors.lastname: Fraser
mesh_terms: D000293:Adolescent; D000328:Adult; D001485:Basement Membrane / Q000648:ultrastructure*; D001706:Biopsy; D001808:Blood Vessels / Q000737:chemistry; D003094:Collagen / Q000032:analysis; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D004343:Drug Implants; D004717:Endometrium / Q000098:blood supply*; D004730:Endothelium, Vascular / Q000648:ultrastructure*; D004958:Estradiol / Q000097:blood; D005260:Female; D019812:Heparan Sulfate Proteoglycans / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D007797:Laminin / Q000032:analysis; D016912:Levonorgestrel / Q000009:adverse effects*; D011374:Progesterone / Q000097:blood
chemical_list: D003271:Contraceptive Agents, Female; D004343:Drug Implants; D019812:Heparan Sulfate Proteoglycans; D007797:Laminin; D011374:Progesterone; D004958:Estradiol; D016912:Levonorgestrel; D003094:Collagen